Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YH14618 in Degenerative Disc Disease
NCT01526330Phase 2Completed
- Sponsor
- Yuhan
- Start
- May 2012
- Primary completion
- Jan 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of vicatertide in degenerative disc disease (DDD), sponsored by Yuhan. Started May 2012; status: completed.
02
Drugs
vicatertide
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT01526330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01526330.